A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance To...

Overview

Journal Psychedelic Med (New Rochelle)

Date 2025 Mar 6

PMID 40047006

Authors

Meghan Hibicke

Hannah M Kramer

Charles D Nichols

Affiliations

Soon will be listed here.

Abstract

Introduction: Psilocybin has shown long-lasting antidepressant effects in preclinical and clinical trials, but the mechanisms responsible are unclear. As both passive coping strategies and pattern separation deficits are characteristics of major depression, we used adult female rats subjected to adolescent chronic restraint stress (aCRS) to investigate the effects of psilocybin on forced swim test (FST) and object pattern separation (OPS) behaviors 5 weeks after a single administration.

Methods: Adolescent rats were randomly assigned to one of four treatment groups-not restrained/saline, not restrained/psilocybin, restrained/saline, and restrained/psilocybin. Restrained group rats were restrained for 1 h daily from day 1 through day 14. Saline and psilocybin were administered on day 21, OPS was evaluated on days 51-55, forced swim behavior was evaluated on day 57 or 58, and animals were sacrificed on day 63. Brains were removed and the medial prefrontal cortex, dorsal dentate gyrus, dorsal CA3 hippocampal area, and ventral hippocampus were microdissected out and prepared for mRNA analysis of a panel of genes relevant to synaptic plasticity using quantitative polymerase chain reaction.

Results: Psilocybin rescued cognitive function in aCRS rats in both assays, but did not affect either measure in nonstressed rats. Immobility in the FST was correlated with impaired discrimination ability in the OPS. No differences in mRNA expression for a panel of genes related to structural synaptic proteins were observed between groups, although stress was a significant contributor to variability of the gene for glutamate metabotropic receptor 2 () in two hippocampal regions.

Conclusions: Our data indicate that aCRS and OPS represent a powerful system with translational relevance to study depression, and that a single treatment with psilocybin has long-lasting antidepressant-like effects without long-term alterations of mRNA related to synaptic density in brain areas relevant to depression.

Citing Articles

Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles.

Rogers S, Heller E, Corder G bioRxiv. 2024; .

PMID: 38352491 PMC: 10862786. DOI: 10.1101/2024.02.04.578811.

References

Davis M, Walters J . Psilocybin: biphasic dose-response effects on the acoustic startle reflex in the rat. Pharmacol Biochem Behav. 1977; 6(4):427-31. DOI: 10.1016/0091-3057(77)90180-0. View

Commons K, Cholanians A, Babb J, Ehlinger D . The Rodent Forced Swim Test Measures Stress-Coping Strategy, Not Depression-like Behavior. ACS Chem Neurosci. 2017; 8(5):955-960. PMC: 5518600. DOI: 10.1021/acschemneuro.7b00042. View

Krubitzer L, Campi K, Cooke D . All rodents are not the same: a modern synthesis of cortical organization. Brain Behav Evol. 2011; 78(1):51-93. PMC: 3182045. DOI: 10.1159/000327320. View

Kempermann G, Jessberger S, Steiner B, Kronenberg G . Milestones of neuronal development in the adult hippocampus. Trends Neurosci. 2004; 27(8):447-52. DOI: 10.1016/j.tins.2004.05.013. View

Carhart-Harris R, Roseman L, Bolstridge M, Demetriou L, Nienke Pannekoek J, Wall M . Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Sci Rep. 2017; 7(1):13187. PMC: 5640601. DOI: 10.1038/s41598-017-13282-7. View

Jones K, Srivastava D, Allen J, Strachan R, Roth B, Penzes P . Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling. Proc Natl Acad Sci U S A. 2009; 106(46):19575-80. PMC: 2780750. DOI: 10.1073/pnas.0905884106. View

Griffiths R, Johnson M, Carducci M, Umbricht A, Richards W, Richards B . Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol. 2016; 30(12):1181-1197. PMC: 5367557. DOI: 10.1177/0269881116675513. View

Luethi D, Liechti M . Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics. Int J Neuropsychopharmacol. 2018; 21(10):926-931. PMC: 6165951. DOI: 10.1093/ijnp/pyy047. View

Ly C, Greb A, Cameron L, Wong J, Barragan E, Wilson P . Psychedelics Promote Structural and Functional Neural Plasticity. Cell Rep. 2018; 23(11):3170-3182. PMC: 6082376. DOI: 10.1016/j.celrep.2018.05.022. View

10.

Inserra A, Campanale A, Cheishvili D, Dymov S, Wong A, Marcal N . Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling. Prog Neuropsychopharmacol Biol Psychiatry. 2022; 119:110594. DOI: 10.1016/j.pnpbp.2022.110594. View

11.

Ally B, Hussey E, Ko P, Molitor R . Pattern separation and pattern completion in Alzheimer's disease: evidence of rapid forgetting in amnestic mild cognitive impairment. Hippocampus. 2013; 23(12):1246-58. PMC: 4310474. DOI: 10.1002/hipo.22162. View

12.

Sinyor M, Schaffer A, Levitt A . The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review. Can J Psychiatry. 2010; 55(3):126-35. DOI: 10.1177/070674371005500303. View

13.

Magaraggia I, Kuiperes Z, Schreiber R . Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach. Neurobiol Learn Mem. 2021; 183:107467. DOI: 10.1016/j.nlm.2021.107467. View

14.

Benneyworth M, Smith R, Barrett R, Sanders-Bush E . Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice. Psychopharmacology (Berl). 2005; 179(4):854-62. DOI: 10.1007/s00213-004-2108-z. View

15.

Millard S, Weston-Green K, Newell K . The Wistar-Kyoto rat model of endogenous depression: A tool for exploring treatment resistance with an urgent need to focus on sex differences. Prog Neuropsychopharmacol Biol Psychiatry. 2020; 101:109908. DOI: 10.1016/j.pnpbp.2020.109908. View

16.

Levkovitz Y, Caftori R, Avital A, Richter-Levin G . The SSRIs drug Fluoxetine, but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression. Brain Res Bull. 2002; 58(4):345-50. DOI: 10.1016/s0361-9230(01)00780-8. View

17.

Dalla C, Shors T . Sex differences in learning processes of classical and operant conditioning. Physiol Behav. 2009; 97(2):229-38. PMC: 2699937. DOI: 10.1016/j.physbeh.2009.02.035. View

18.

van Goethem N, van Hagen B, Prickaerts J . Assessing spatial pattern separation in rodents using the object pattern separation task. Nat Protoc. 2018; 13(8):1763-1792. DOI: 10.1038/s41596-018-0013-x. View

19.

Woo E, Sansing L, Arnsten A, Datta D . Chronic Stress Weakens Connectivity in the Prefrontal Cortex: Architectural and Molecular Changes. Chronic Stress (Thousand Oaks). 2021; 5:24705470211029254. PMC: 8408896. DOI: 10.1177/24705470211029254. View

20.

Rong C, Park C, Rosenblat J, Subramaniapillai M, Zuckerman H, Fus D . Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder. Int J Environ Res Public Health. 2018; 15(4). PMC: 5923813. DOI: 10.3390/ijerph15040771. View